Ipragliflozin CAS: 761423-87-4
| Product Parameters | |
|---|---|
| Catalog No. | BA9X05 |
| CAS.RN | 761423-87-4 |
| Molecular Formula | C21H21FO5S |
| Molecular Weight | 404.45 g/mol |
| Purity | NLT 98% |
Product Overview
Ipragliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor, primarily used in the development and production of active pharmaceutical ingredients (APIs) for diabetes treatment. This product is suitable for the entire process of drug development, small-scale preparation, pilot-scale amplification, and commercial production. It exhibits excellent biological activity and pharmacokinetic properties and is widely used in the process development and quality control of novel hypoglycemic drugs. As a core intermediate or API, ipragliflozin holds significant value in the pharmaceutical and chemical industry, providing customers with a stable and compliant supply guarantee.
Applications
- Diabetes Drug Development
- Synthesis of SGLT2 Inhibitors
- Drug Process Route Optimization
- Pilot-Scale and Commercial Production
- Customized API Supply
Quality & Supply Capability
English Name: Ipragliflozin Properties: White to off-white crystalline powder, readily soluble in organic solvents, with a stable molecular structure and well-defined functional groups, meeting pharmaceutical-grade API standards. Storage Recommendations: Store in a sealed, light-protected, and dry place, subject to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide comprehensive services from laboratory sample supply to small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust supply solutions according to customers' specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documentation. Simultaneously, we have a professional technical support team to assist customers in completing the entire process from laboratory R&D to industrial production, including process development, route optimization, and project transformation, ensuring product quality and delivery efficiency to meet the R&D and production needs of various pharmaceutical companies.
Why Choose Bioncan
Focused on supplying SGLT2 inhibitor APIs with extensive industry experience. Full-scale supply capability, covering everything from sample to commercial-scale production. Provides complete quality control documentation to ensure product compliance and stability. Supports customized needs, flexibly addressing the technical and quality requirements of different clients. Provides process optimization and scale-up technical support to help clients efficiently advance their R&D and production processes.
Intermediates of Ipragliflozin
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA9X05 | Ipragliflozin API | 761423-87-4 |
| BK7Q8G | D-Gluconic acid, 2,3,4,6-tetrakis-O-(trimethylsilyl)-, δ-lactone | 32384-65-9 |
| BK9AH5 | (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | 1034305-21-9 |
| BK77NU | Benzo[b]thiophene, 2-[(5-bromo-2-fluorophenyl)methyl]- | 1034305-17-3 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 761423-87-4, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.
